17 Apr 2019
Golden Meditech and HKBU Team up to Conduct Cell Therapy Research
Hong Kong, 17 April 2019 - Golden Meditech Holdings Limited (SEHK stock code: 00801) ("Golden Meditech"), a leading integrated healthcare enterprise in China, announced that it has formed a collaboration with the Department of Biology of Hong Kong Baptist University ("HKBU") to conduct in-depth research in the area of cell therapy, particularly treating neurodegenerative diseases with stem cells.

Please download the latest "Acrobat Reader" to view the PDF.

Back to top